66 results
6-K
TAK
Takeda Pharmaceutical Co
13 Nov 23
Current report (foreign)
6:05am
and Debilitating Chronic Symptoms
Takeda Continues 70-plus Year Legacy of Driving Innovation for the Rare Hematology Community
OSAKA, Japan, and CAMBRIDGE … ADZYNMA as the first FDA-approved therapeutic option for people with cTTP.”
cTTP is an ultra-rare, chronic blood clotting disorder caused
6-K
TAK
Takeda Pharmaceutical Co
17 May 23
Current report (foreign)
6:02am
for cTTP, a disorder with considerable unmet patient need.
cTTP is an ultra-rare inherited form of thrombotic thrombocytopenic purpura (TTP), a chronic … deficiency.
ABOUT cTTP
cTTP is an ultra-rare, chronic, and debilitating clotting disorder associated with life-threatening acute episodes and debilitating
6-K
EX-99.2
TAK
Takeda Pharmaceutical Co
21 Nov 19
Current report (foreign)
6:08am
development Data‐driven guidelines for acute and chronic management 30
PDT R&D Strategy Maximize the therapeutic Realize full potential of in‐line First … Flextronics Chronic inflammatory demyelinating Delivery Device polyneuropathy (CIDP) HYQVIA CINRYZE Geographic expansion Geographic expansion IMMUNOLOGY
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
15 Nov 19
Current report (foreign)
6:24am
. Only select SIDs are approved for the above‐mentioned products: chronic lymphocytic leukemia, multiple myeloma and hematopoietic stem cell 27 … of Care services and drug delivery services New process development Data‐driven guidelines for acute and chronic management 38
PDT R&D Strategy
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
8 Dec 20
Current report (foreign)
6:01am
) Higher risk-Myelodysplastic syndromes Unfit Acute myeloid leukemia $400 – 800MN TAK-007 3L+ Diffuse Large B-Cell Lymphoma 3L+ Chronic Lymphocytic … , leadership needed TAK-721 is specifically designed to tackle EoE Takeda is strongly positioned to launch TAK-721 Chronic inflammatory disease which
6-K
94t8 kg7od3q
4 Feb 19
Current report (foreign)
6:07am
6-K
EX-99.1
v5702enxt
11 Jan 22
Current report (foreign)
6:02am
6-K
ifqrad
11 Sep 23
Current report (foreign)
6:50am
6-K
co0bepv
10 Feb 22
Current report (foreign)
6:03am
6-K
gdybc5v t4iso6f6pdl0
12 Aug 20
Current report (foreign)
6:10am
6-K
EX-99.1
nhhepv8p ma309u25dyk
21 Nov 19
Current report (foreign)
6:08am
6-K
EX-99.1
sru3sjt
14 Nov 19
Current report (foreign)
6:26am
6-K
3utz99mixtnmcdp4bhhp
14 May 19
Current report (foreign)
3:33pm
6-K
4t9q1cxx zklfua
12 Feb 21
Current report (foreign)
6:04am
6-K
EX-99.1
hhpt7g
28 May 21
Current report (foreign)
6:04am
6-K
62fm dsglop
9 Feb 24
Current report (foreign)
6:03am
6-K
EX-99.1
xjh1 pob8pxn
6 Apr 21
Current report (foreign)
6:29am
6-K
5dx33cl2783968vs
31 Jul 20
Current report (foreign)
8:45am
6-K
9rkt5utmqyt2h8
5 Nov 21
Current report (foreign)
6:02am
6-K
3yc c38ge5l
6 Aug 21
Current report (foreign)
6:06am